News
Jobs Week Helps Boost Market Sentiment
Wednesday, June 3rd, 2026
Jobs Week Coming Up Roses So Far: JOLTS, ADP
Don’t look now, but the labor market in the U.S. has demonstrably improved. Where we had been at historic lows on job openings
Block's Cash App Adds Afterpay BNPL: Will This Drive User Engagement?
Block XYZ recently announced the launch of Afterpay on Cash App Card, bringing eligible Cash App card customers under the sphere of Buy Now, Pay Later (“BNPL”). This arrangement has been designed
Manufacturing ETF (MADE) Hits New 52-Week High
iShares U.S. Manufacturing ETF MADE is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 51.38% from its 52-week low price of $25.30 per share.
Is BB Stock Still a Buy After a Triple-Digit Surge in 6 Months?
BlackBerry Limited’s BB shares have rallied 153.2% in the past six months, outperforming the Computer Software industry (down 6.8%) and the S&P 500 composite (rise of 10.9%). Yesterday, BB stock
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, you can try the growth at a reasonable price or GARP strategy.The strategy helps investors
Slice of the Pie: Why Yum’s Deal Lifts QSR
Key Points
- Interested in Yum! Brands, Inc.? Here are five stocks we like better.
- Yum! Brands is in exclusive talks to sell Pizza Hut to LongRange Capital in a deal valued between $3.6 billion and
GSK Bets on Specialty Medicines to Drive Long-Term Revenue Growth
GSK plc’s GSK Specialty Medicines business has become the company's primary growth engine, accounting for more than 40% of total sales and growing at a double-digit rate. The segment spans four core
5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation
2 Domestic Auto Giants Worth Holding Despite Industry Weakness
Can AstraZeneca's Expanding Cancer Portfolio Sustain Momentum?
Over the past decade, AstraZeneca AZN has built a broad oncology franchise spanning multiple cancer types, including lung, breast, blood, gastrointestinal and genitourinary cancers. The segment
DWS Group GmbH & Co. KGaA Sets 2028 Targets After Record Results, Dividend Hike at AGM
Key Points
- Interested in DWS Group GmbH & Co. KGaA? Here are five stocks we like better.
- DWS posted record 2025 results, with revenue of EUR 3.155 billion, net income of EUR 927 million and
Macy's Q1 Earnings Call Highlights
Key Points
- Interested in Macy's, Inc.? Here are five stocks we like better.
- Macy’s beat first-quarter expectations across sales, comparable sales, EBITDA and EPS, with CEO Tony Spring saying
Sprinklr Q1 Earnings Call Highlights
Key Points
- Interested in Sprinklr, Inc.? Here are five stocks we like better.
- Sprinklr beat Q1 expectations, with revenue up 7% year over year to $219.5 million and non-GAAP operating income
Rent the Runway Q1 Earnings Call Highlights
Key Points
- Interested in Rent the Runway, Inc.? Here are five stocks we like better.
- Rent the Runway delivered a strong fiscal Q1 2026, with revenue of $89.9 million, up 29.2% year over year
Ollie's Bargain Outlet Q1 Earnings Call Highlights
Key Points
- Interested in Ollie's Bargain Outlet Holdings, Inc.? Here are five stocks we like better.
- Q1 results topped expectations with net sales up 14% to $659 million, comparable-store
Cognyte Software Q1 Earnings Call Highlights
Key Points
- Interested in Cognyte Software Ltd.? Here are five stocks we like better.
- Cognyte reported first-quarter fiscal 2027 revenue of $105.5 million, up 10.4% year over year, and
MiniMed Group Q4 Earnings Call Highlights
Key Points
- Interested in MiniMed Group Inc? Here are five stocks we like better.
- MiniMed posted record fiscal 2026 results, with annual revenue topping $3 billion for the first time and
South Korea's Market Rally May Be Far From Over: ETFs to Consider
The strength of investor conviction in the AI theme can be seen in South Korea's market performance. The country has become one of Asia's standout growth stories, with its market rally gaining
AbbVie Gets EU Nod for Aquipta as Acute Treatment for Migraine
AbbVie ABBV announced that the European Commission has approved Aquipta (atogepant) for the acute treatment of migraine in adults with or without aura, to be taken as needed.
This marks the second
Stitch Fix (SFIX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Stitch Fix (SFIX) reports results for the quarter ended April 2026. While this widely-known consensus
Chewy (CHWY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Chewy (CHWY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus outlook is
Oracle (ORCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Oracle (ORCL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended May 2026. This widely-known consensus outlook gives a
Best Momentum Stocks to Buy for June 3rd
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, June 3:
Dell Technologies Inc. DELL: This information technology solutions, products and